Health & Wellness
Nowadays, doctors throughout the world report that the novel coronavirus infection COVID-19 occurs in different people in completely different ways. Combinations of symptoms that are dissimilar, ranging from coughing to digestive disorders, make diagnosis difficult. Additionally, scientists and doctors still do not understand why people of the same age and with comparable health indicators can transmit the infection so differently from each other: some require ventilator support to stay alive, while others do not feel sick at all. One of the possible causes of this phenomenon may be a different level of von Willebrand factor (VWF) in the blood of patients.
The scariest part of this is they will have the ability to trace all food, down to the individual coffee bean, from it's inception right until it gets into your cup. This is a level of control never before seen on planet earth.
Tune in to this episode of Objective:Health as we look into the deeper implications of Project Salus.
And check us out on Brighteon!
For other health-related news and more, you can find us on:
♥Twitter: https://twitter.com/objecthealth
♥Facebook: https://www.facebook.com/objecthealth/
♥Brighteon: https://www.brighteon.com/channel/objectivehealth
♥And you can check out all of our previous shows (pre YouTube) here.
Running Time: 00:34:08
Download: MP3 — 31.3 MB
A few years ago, I wrote a book called Doctoring Data. This was an attempt to help people understand the background to the tidal wave of medical information that crashes over us each and every day. Information that is often completely contradictory, viz 'Coffee is good for you... no, wait it's bad for you... no, wait, it's good for you again,' repeated ad nauseam.
I also pointed out some of the tricks, games and manipulations that are used to make medications seem far more effective than they truly are, or vice versa. This, I have to say, can be a very dispiriting world to enter. When I give talks on this subject, I often start with a few quotes.
Comment: See also:
- Disastrous response to Covid-19: 'The lockdown is causing so many deaths'
- Quarantine - Is it worth it?
- Big Pharma has been busy distorting science during the pandemic
- Focus on Vitamin D for COVID (and much more)
- Dr. Malcolm Kendrick - Some measures you can take against the Covid-19
- Dr. Malcolm Kendrick - A second look at vaccination - answers that cannot be questioned
- Dr. Malcolm Kendrick - The vaccination debate
- Doctoring Data - Science has turned to darkness
- Results from a controlled trial of hydroxychloroquine for COVID-19
- Vindicated: Trump-touted COVID-19 drug hydroxychloroquine works, according to new study
- Los Angeles doctor reports remarkable success treating COVID-19 patients with hydroxychloroquine & zinc
Never in history have we seen such a determined effort by the scientific community and pharmaceutical industry to downplay and lie about the use of a successful drug to treat a deadly disease.
Hydroxychloroquine is the first choice in a study of 6,000 doctors treating the coronavirus. In the field and in independent testing hydroxychloroquine displayed amazing results in treating the COVID-19 virus.
Comment: See also:
- Gilead's coronavirus treatment remdesivir to cost $3,120 per U.S. patient with private insurance
- WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death
- Vindicated: Trump-touted COVID-19 drug hydroxychloroquine works, according to new study
- FDA revokes emergency use of hydroxychloroquine
- Hydroxychloroquine study which caused WHO to halt trials for Covid-19 now under scrutiny - UPDATE
The case was registered at a hospital in China's Inner Mongolia region, its health commission said in a statement on Sunday.
This prompted a third-level warning of a potential epidemic in the region. The alert comes into force immediately and will be in place until the end of this year. It's believed the patient in question is suffering from the bubonic form, which causes swollen lymph nodes, and is considered to be the most easily treated variant of the disease.
Evidence that a cheap, over-the-counter anti-malarial drug costing £7 combats COVID-19 gets trashed. Why? Because the pharmaceutical giants want to sell you a treatment costing nearly £2,000. It's criminal.
A few years ago, I wrote a book called Doctoring Data. This was an attempt to help people understand the background to the tidal wave of medical information that crashes over us each and every day. Information that is often completely contradictory 'Coffee is good for you... no, wait it's bad for you... no, wait, it's good for you again,' repeat ad nauseam.
I also pointed out some of the tricks, games and manipulations that are used to make medications seem far more effective than they truly are, or vice-versa. This, I have to say, can be a very dispiriting world to enter. When I give talks on this subject, I often start with a few quotes.
For example, here is Dr Marcia Angell, who edited the New England Journal of Medicine for over twenty years, writing in 2009:
"It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgement of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as editor of the New England Journal of Medicine."Have things got better? No, I believe that they have got worse - if that were, indeed, possible. I was sent the following e-mail recently, about a closed door, no recording discussion, under no-disclosure Chatham House rules, in May of this year:
"A secretly recorded meeting between the editors-in-chief of The Lancet and the New England Journal of Medicine reveal both men bemoaning the 'criminal' influence big pharma has on scientific research.A YouTube video where this issue is discussed can be found here. It is in French, but there are English subtitles.
"According to Philippe Douste-Blazy, France's former Health Minister and 2017 candidate for WHO Director, the leaked 2020 Chatham House closed-door discussion between the [editor-in-chiefs] - whose publications both retracted papers favorable to big pharma over fraudulent data.
"Now we are not going to be able to, basically, if this continues, publish any more clinical research data because the pharmaceutical companies are so financially powerful today, and are able to use such methodologies, as to have us accept papers which are apparently methodologically perfect, but which, in reality, manage to conclude what they want them to conclude," said Lancet [editor-in-chief] Richard Horton."
The setback came as the WHO also reported more than 200,000 new cases globally of the disease for the first time in a single day. The United States accounted for 53,213 of the total 212,326 new cases recorded on Friday, the WHO said.
"These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalised COVID-19 patients when compared to standard of care. Solidarity trial investigators will interrupt the trials with immediate effect," the WHO said in a statement, referring to large multicountry trials that the agency is leading.
Comment: Make no mistake: the slamming of hydroxychloroquine is a political move, not a medical one. With the amount of evidence showing a reduction in mortality from the use of hydroxychloroquine, and the clear push for the insanely expensive remdesivir as the preferred drug, one can clearly see which way the money flows. Not to mention the fact that the hundreds of Covid vaccines currently under development, with potential massive payoffs, will be rendered useless should a cheap and effective treatment be found. This is not about 'saving lives', it's about a particular group of people making sure they profit stupendously from the created fear and desperation of the populace.
See also:
- Vindicated: Trump-touted COVID-19 drug hydroxychloroquine works, according to new study
- FDA revokes emergency use of hydroxychloroquine
- Hydroxychloroquine study which caused WHO to halt trials for Covid-19 now under scrutiny - UPDATE
- "Most of the world's leaders use it as a prophylaxis" - President of El Salvador on hydroxychloroquine for coronavirus
- French gov't submitting to pressure from pharma labs by banning hydroxychloroquine, politician claims
- Spain, US & Russia using Hydroxychloroquine to treat coronavirus while France, Italy and Belgium ban it due to WHO concerns
- France revokes decree authorizing use of hydroxychloroquine to treat Covid-19
- WHO suspends hydroxychloroquine clinical trial, touted by Trump as 'coronavirus cure', stating safety fears
- Association of American Physicians and Surgeons: Hydroxychloroquine has about 90 percent chance of helping COVID-19 patients
- 'I'm still here': Trump reveals he's been taking Hydroxychloroquine against Covid-19
Since 1962, there have only been 37 reported cases of the amoeba in Florida. This one was found in Hillsborough County, though the DOH did not give any further details.
Naegleria fowleri is typically found in warm freshwater like lakes, rivers and ponds. The DOH has cautioned people who swim in those freshwater sources to be aware of the amoeba's possible presence, particularly when the water is warm.
In contrast, some of the biggest and most experienced vaccine manufacturers in the U.S. and globally, including Merck, Sanofi and GlaxoSmithKline (GSK), seemed, until recently, to be missing in action — "conspicuously absent" from the frontrunner lists. In May, a Merck executive explained the relative silence this way: "It's not that the company wasn't working on the problem, . . . but that it simply wasn't ready to speak." Meanwhile, GSK — which leads the world in global vaccine revenues — has been casting itself as the wise old granddaddy in a sea of impetuous upstarts, modestly stating its preference for "the slow and steady approach of focusing on an established technology that has the best chance of reaching the widest possible demographic."
In late spring, GSK apparently decided to reverse its tortoise-like approach and stepped boldly out of the shadows. After having already made its "established technology" — that is, GSK's "pandemic vaccine adjuvant system" — available to several regional players earlier in the year, a splashy mid-April announcement reported that GSK would override its ordinarily fierce competition with Sanofi to embark on a Covid-19 vaccine joint effort, pooling both know-how and manufacturing capacity with the French pharma giant. Under this "unprecedented" arrangement, Sanofi will provide the coronavirus antigen while GSK ponies up its trademark AS03 adjuvant system.
Comment: See also:
- Protests in Johannesburg as Oxford University Covid-19 vaccine trials begin in Africa
- Russia to prepare 70 million doses of Covid-19 vaccine, lead scientist hopes it will provide immunity for more than 2 years
- We don't need no stinking vaccine for Covid-19
- Colorado bill requires "re-education" for parents who refuse the COVID-19 vaccine
- Damage control: Bill Gates tries to counter Covid-19 vaccine conspiracy theories he's pegged to
- He experienced a severe reaction to Moderna's Covid-19 vaccine candidate. He's still a believer
- Oxford's COVID-19 vaccine trial has 50% chance of success, says report
- Robert F. Kennedy, Jr.: 100% Injury rate in subjects from Gates-backed Covid-19 vaccine - UK Vax group fails
Dr. John Ioannidis became a world-leading scientist by exposing bad science. But the COVID-19 pandemic could prove to be his biggest challenge yet.
Ioannidis, the C.F. Rehnborg Chair in Disease Prevention at Stanford University, has come under fire in recent months for his opposition to state-ordered lockdowns, which he says could cause social harms well beyond their presumed benefits. But he doesn't appear to be backing down.
Comment: See also:
- Stanford researcher Dr. John Ioannidis says coronavirus might not be as deadly as flu
- Ioannidis releases new medical analysis of 12 global coronavirus studies finding 9 of 12 show COVID-19 fatality rates similar to seasonal flu
- Stanford U. epidemiologist John Ioannidis lambasts the media for panicking the public over Covid-19
- World's leading epidemiologist John Ioannidis on COVID-19 fiasco: 'We are making decisions without reliable data'















Comment: See also:
- UK's Muslim males had highest lockdown death rate, Jews more than double
- Compelling Evidence That SARS-CoV-2 Was Man-Made
- Everything You Think You Know About Coronavirus...
- Leading Russian scientist says genetics & blood type can determine risk of death from Covid-19 infection
- Higher risk of heart attack for certain blood groups
And check out SOTT radio's: Objective:Health - The Ultimate Insanity of the Covid Lockdown - Interview with Sott.net Editor Joe Quinn